Genic Co. Ltd (123330) — Capital Reinvestment Ratio
Genic Co. Ltd (123330) has a Capital Reinvestment Ratio of 0.12x as of December 2025, meaning it reinvests 0% of its operating cash flow (₩7.70 Billion) in capital expenditures (₩958.13 Million). See Genic Co. Ltd (123330) balance sheet quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Genic Co. Ltd Capital Reinvestment Ratio (2012–2025)
This chart tracks Genic Co. Ltd's Capital Reinvestment Ratio across 11 annual periods. Check 123330 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Genic Co. Ltd (2012–2025)
Year-by-year Capital Reinvestment Ratio for Genic Co. Ltd from 2012 to 2025. For live market cap and broader valuation context, see 123330 market cap overview.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.13x | ₩20.65 Billion | ₩2.68 Billion | ▼ -97.9% |
| 2024 | 6.06x | ₩272.46 Million | ₩1.65 Billion | ▼ -24.2% |
| 2022 | 8.00x | ₩177.94 Million | ₩1.42 Billion | ▲ +3984.9% |
| 2021 | 0.20x | ₩3.32 Billion | ₩650.83 Million | ▼ -94.6% |
| 2020 | 3.62x | ₩212.66 Million | ₩769.27 Million | ▲ +499.4% |
| 2019 | 0.60x | ₩1.38 Billion | ₩830.95 Million | ▼ -86.5% |
| 2016 | 4.48x | ₩1.93 Billion | ₩8.63 Billion | ▲ +20.7% |
| 2015 | 3.71x | ₩3.63 Billion | ₩13.48 Billion | ▲ +89.2% |
| 2014 | 1.96x | ₩5.80 Billion | ₩11.39 Billion | ▼ -17.0% |
| 2013 | 2.36x | ₩3.68 Billion | ₩8.69 Billion | ▲ +130.9% |
| 2012 | 1.02x | ₩4.31 Billion | ₩4.41 Billion | — |